Contemporary rates of appropriate shock therapy in patients who receive implantable device therapy in a real-world setting: From the Israeli ICD Registry

Heart Rhythm

Volumn 12, Issue 12, 2015, Pages 2426-2433

  Sabbag, Avi ^a   Suleiman, Mahmoud ^b   Laish Farkash, Avishag ^c   Samania, Nimer ^b   Kazatsker, Mark ^d   Goldenberg, Ilan ^a   Glikson, Michael ^a   Beinart, Roy ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b Cardiology Department   (Israel)

^c BARZILAI MEDICAL CENTER   (Israel)

^d HILLEL YAFFE MEDICAL CENTER   (Israel)

Author keywords

Appropriate shock; Defibrillator; Heart failure; Primary prevention

Indexed keywords

ADULT; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIAC RESYNCHRONIZATION THERAPY DEVICE; CONVULSIVE THERAPY; FEMALE; FOLLOW UP; HEART DEATH; HEART FAILURE; HOSPITALIZATION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; ISRAELI; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIMARY PREVENTION; PRIORITY JOURNAL; REGISTER; SECONDARY PREVENTION; SURVIVAL; AGED; CARDIOVERSION; COHORT ANALYSIS; COMPLICATION; DEATH, SUDDEN, CARDIAC; ISRAEL; KAPLAN MEIER METHOD; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; TACHYCARDIA;

AGED; COHORT STUDIES; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; ISRAEL; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; REGISTRIES; TACHYCARDIA;

EID: 84959921896     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2015.08.020     Document Type: Article

References (21)

1. A.J. Moss, W. Zareba, W.J. Hall, H. Klein, D.J. Wilber, D.S. Cannom, J.P. Daubert, S.L. Higgins, M.W. Brown, and M.L. Andrews Multicenter Automatic Defibrillator Implantation Trial III. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction New Engl J Med 346 2002 877 883
2. G.H. Bardy, K.L. Lee, D.B. Mark, and et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure New Engl J Med 352 2005 225 237
3. E.F. Wever, R.N. Hauer, F.L. van Capelle, J.G. Tijssen, H.J. Crijns, A. Algra, A.C. Wiesfeld, and P.F. Bakker Robles de Medina EO. Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors Circulation 91 1995 2195 2203
4. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators New Engl J Med 337 1997 1576 1583
5. A.E. Buxton, K.L. Lee, J.D. Fisher, M.E. Josephson, E.N. Prystowsky, and G. Hafley A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators New Engl J Med 341 1999 1882 1890
6. A. Kadish, A. Dyer, J.P. Daubert, and et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy New Engl J Med 350 2004 2151 2158
7. A.E. Epstein, J.P. Dimarco, K.A. Ellenbogen, and et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary Heart Rhythm 5 2008 934 955
8. K. Dickstein, P.E. Vardas, A. Auricchio, J.C. Daubert, C. Linde, J. McMurray, P. Ponikowski, S.G. Priori, R. Sutton, and D.J. van Veldhuisen Guidelines ESCCfP. 2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association Eur Heart J 31 2010 2677 2687
9. S.C. Hammill, M.S. Kremers, L.W. Stevenson, and et al. Review of the registry's fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure Heart Rhythm 7 2010 1340 1345
10. A.J. Moss, C. Schuger, C.A. Beck, and et al. Reduction in inappropriate therapy and mortality through ICD programming New Engl J of Med 367 2012 2275 2283
11. J. Buber, D. Luria, O. Gurevitz, D. Bar-Lev, M. Eldar, and M. Glikson Safety and efficacy of strategic implantable cardioverter-defibrillator programming to reduce the shock delivery burden in a primary prevention patient population Europace 16 2014 227 234
12. S. Cay, U. Canpolat, F. Ucar, O. Ozeke, F. Ozcan, S. Topaloglu, and D. Aras Programming implantable cardioverter-defibrillator therapy zones to high ranges to prevent delivery of inappropriate device therapies in patients with primary prevention: results from the RISSY-ICD (Reduction of Inappropriate ShockS bY InCreaseD zones) trial Am J Cardiol 115 2015 1235 1243
13. Sabbag A, Suleiman M, Glick A, Medina A, Golovchiner G, Steiner H, Arad M, Goldenberg I, Glikson M, Beinart R. Ethnic Differences Among Implantable Cardioverter Defibrillators Recipients in Israel. Am J Cardiol;115:1102-1106.
14. B.L. Wilkoff, B.D. Williamson, R.S. Stern, and et al. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study J Am Coll Cardiol 52 2008 541 550
15. A.J. Moss, W.J. Hall, D.S. Cannom, J.P. Daubert, S.L. Higgins, H. Klein, J.H. Levine, S. Saksena, A.L. Waldo, D. Wilber, M.W. Brown, and M. Heo Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators New Engl J of Med 335 1996 1933 1940
16. A. Arya, M. Haghjoo, M.R. Dehghani, M. Alasti, H. Alizadeh, B. Kazemi, and M.A. Sadr-Ameli Effect of cardiac resynchronization therapy on the incidence of ventricular arrhythmias in patients with an implantable cardioverter-defibrillator Heart Rhythm 2 2005 1094 1098
17. G. Ouellet, D.T. Huang, A.J. Moss, W.J. Hall, A. Barsheshet, S. McNitt, and H. Klein Zareba W, Goldenberg I. Effect of cardiac resynchronization therapy on the risk of first and recurrent ventricular tachyarrhythmic events in MADIT-CRT J Am Coll Cardiol 60 2012 1809 1816
18. J.A. Manfredi, S.M. Al-Khatib, L.K. Shaw, L. Thomas, R.I. Fogel, B. Padanilam, D. Rardon, R. Vatthyam, L.W. Gemma, K. Golden, and E.N. Prystowsky Association between left ventricular ejection fraction post-cardiac resynchronization treatment and subsequent implantable cardioverter defibrillator therapy for sustained ventricular tachyarrhythmias Circulation Arrhythmia and Electrophysiology 6 2013 257 264
19. V. Kutyifa, A.C. Pouleur, D. Knappe, A. Al-Ahmad, M. Gibinski, P.J. Wang, S. McNitt, B. Merkely, I. Goldenberg, S.D. Solomon, and A.J. Moss Zareba W. Dyssynchrony and the risk of ventricular arrhythmias JACC Cardiovascular Imaging 6 2013 432 444
20. A.J. Moss, H. Greenberg, R.B. Case, W. aZareba, W.J. Hall, M.W. Brown, J.P. Daubert, S. McNitt, M.L. Andrews, and A.D. Elkin Multicenter Automatic Defibrillator Implantation Trial IIRG. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator Circulation 110 2004 3760 3765
21. K. Narayanan, K. Reinier, A. Uy-Evanado, C. Teodorescu, H. Chugh, E. Marijon, K. Gunson, J. Jui, and S.S. Chugh Frequency and determinants of implantable cardioverter defibrillator deployment among primary prevention candidates with subsequent sudden cardiac arrest in the community Circulation 128 2013 1733 1738